Home > Service offer > Quality control programme >
| Screening | (µg/l) | Confirmation | (µg/l) |
|---|---|---|---|
| opiatesa | 300 | total morphinea,b,c | 200 |
| cocainea (metabolites) | 300 | benzoylecgoninea,b | 150 |
| amphetaminesa (metabolites) | 300 | amphetamine | 200 |
| metaamphetaminea | 200 | ||
| MDMAa | 200 | ||
| MDAa | 200 | ||
| MDEAa | 200 | ||
| cannabinoidsa | 50 | 11-nor-9-COOH-Δ9-THCa | 15 |
| benzodiazepines | 300 | oxazepam | 100 |
| nordiazepam | 100 | ||
| 7-aminoflunitrazepam | 100 | ||
| methadone | 300 | methadone | 300 |
| EDDP | 200 | ||
| dextropropoxyphene | 300 | dextropropoxyphene | 300 |
| norpropoxyphene | 200 | ||
| buprenorphine | 5 | buprenorphine | 5 |
| LSD | 1 | LSD | 1 |
| Barbiturates | 200 | Secobarbital | 150 |
a. Recommendation from the Group of European Experts (Revista de Toxicologia, 1997, 14:19).
b. Identification of specific substances might be needed for an accurate interpretation of results. Therefore, PCQ includes the analysis of the following substances routinely:
c. Free + combined = total morphine (this concentration can only be obtain after the hydrolysis of the sample).
© IMIM Institut de Recerca Hospital del Mar 2008 - Legal Note - Accessibility